Drug Approval | April 15, 2026
CDSCO invites bids for next-gen Digital Drugs Regulatory System
API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India
API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
The campaign builds on the three-year partnership unveiled earlier this season
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
Subscribe To Our Newsletter & Stay Updated
